Back to Authors

Lynch, Kristle L.

https://orcid.org/0000-0002-5481-2499

Mayo Clinic

University of Pennsylvania

Citations 7

Gatherings in Esophagology: Innovations and Future Directions in the Diagnosis and Management of Reflux Disease
Cable, Jennifer, Giuli, R, Fox, Mark , Rosen, Rachel L., Valdovinos‐García, Luis R., Siboni, Stefano, Clarke, John O. , Samuels, Tina L. , Scarpignato, Carmelo , Fass, Ronnie, Remes-Troche, José María, Khan, Abraham, Rahman, Afrin Kamal, Lynch, Kristle L. , Jodorkovsky, Daniela , Vela, Marcelo F. , Vandenberg, Alexandra, Kuo, Braden, Ergün, Pelin , Jirapinyo, Pichamol, Asti, Emanuele, Tolone, Salvatore, Salvador, Renato , Sozzi, Marco, Husain, Inna, Wu, J. , Hobson, Anthony, Sharma, Nirmal , Gyawali, C. Prakash, Sifrim, Daniel, Savarino, E V, Bortoli, Nicola De, Rogers, Benjamin D. , Clarke, J , Valdovinos-García, Luis R. , Siboni, Stefano , Johnston, Nikki , Stein, Ellen M. , Fass, Ronnie , Remes Troche, José M , Kuo, Braden , Jirapinyo, Pichamol , Asti, Emanuele , Sheu, Eric Garland , Sozzi, Marco , Hobson, Anthony, Lo, Wai–Kit , Duncan, Daniel R. , Gyawali, C. Prakash , Chan, Walter W. , Sifrim, Daniel

Annals of the New York Academy of Sciences | March 12, 2026 | Volume: 1557 | Issue: 1 | Pages: No page available

10.1111/nyas.70225 Get It

ABSTRACT Recent advances in the diagnosis and management of reflux disease were the central focus of the inaugural Gatherings in Esophagology (GiE), which convened experts across gastroenterology, surgery, otolaryngology, pulmonology, and basic research. The sessions highlighted innovations in reflux monitoring—including high‐resolution manometry, wireless pH monitoring, and novel salivary biomarkers—while critically evaluating their diagnostic accuracy and clinical utility. Presentations explored the limitations of traditional proton‐pump inhibitor therapy, the emergence of potassium‐competitive acid blockers as a new class of acid suppressants, and the evolving role of adjunctive treatments such as mucosal protectants, reflux reducers, and neuromodulators for refractory symptoms. The discourse extended to advanced interventional procedures, including transoral incisionless fundoplication, magnetic sphincter augmentation, and the RefluxStop device, with discussion of patient selection, efficacy, and complication management. Discussants emphasized the pathophysiology and management of extraesophageal manifestations of reflux, the interplay between reflux and pulmonary disease, and the diagnostic challenges in pediatric populations. The meeting also addressed the integration of behavioral therapies, the role of the microbiome, and the application of artificial intelligence in reflux diagnostics. Collectively, these insights underscore a shift toward precision medicine in reflux disease, emphasizing individualized diagnostic strategies and tailored therapeutic approaches to improve patient outcomes.
Esophageal Expert Development of a Preliminary Question Prompt List for Adults With Eosinophilic Esophagitis: A Modified Delphi Study
Achalu, Sudharshan, Berry, Rani , Joseph, Abel , Bhargava, Meera , Fernandez‐Becker, Nielsen , Chang, Joy W. , Dellon, Evan S. , Hirano, Ikuo , Horsley‐Silva, Jennifer L. , Leiman, David A. , Lynch, Kristle L. , Peterson, Kathryn , Kamal, A. N. , Horsley-Silva, Jennifer, Bredenoord, Albert J. , Falk, Gary W. , Kamal, Afrin N.

Journal of Clinical Gastroenterology | September 23, 2024 | Volume: 59 | Issue: 6 | Pages: 537-541

10.1097/mcg.0000000000002066 Get It

Background: Question prompt lists (QPLs) are structured sets of disease-specific questions intended to encourage question-asking by patients and enhance patient-physician communication. To date, an EoE-specific QPL has not been developed for EoE patients. Aim: To develop a preliminary QPL specific to adults with EoE by incorporating input from international esophageal experts. Methods: Sixteen experts were invited to generate QPL content through a modified Delphi (RAND/University of California, Los Angeles, CA) method consisting of 2 rounds of independent ratings. In round 1, experts provided 5 answers to the prompts “what general questions should patients ask when being seen for EoE?” and “what questions do I not hear patients asking but given my experience, I believe they should be asking?” In round 2, experts rated each question on a 5-point Likert scale, and responses rated as “essential” or “important” (determined by an a priori median threshold of ≥ 4.0) were accepted for the EoE QPL. Results: Ten esophageal experts participated in both rounds. Round 1 generated 100 questions. Questions were combined and modified to reduce redundancy, yielding 57 questions. After round 2, 51 questions (85%) were accepted for inclusion (median value ≥ 4.0) in the final QPL. Questions were then divided into 4 themes based on disease domains: (1) “What is EoE?,” (2) “Treatment Options,” (3) “Follow-up Surveillance and Long-term Risks,” and (4) “Allergy and Genetic Testing.” The largest number of questions covered was “What is EoE?” (16/51 or 31%). Questions with the highest agreement median (5.0) included examples such as “what should I do if I get a food impaction?” and “what are the treatment options?” Conclusion: This is the first preliminary EoE QPL developed in the field of medicine. We hope implementation enhances effective patient-physician communication by encouraging patients to ask relevant questions that experts prioritized. Future studies will aim to modify this communication tool by incorporating patient perspectives
S507 Esophageal Expert Development of a Disease-Specific Question Prompt List for Adults With Eosinophilic Esophagitis: A Modified Delphi Study
Achalu, Sudharshan, Berry, Rani , Bhargava, Meera , Chang, Joy W. , Fernandez‐Becker, Nielsen , Hirano, Ikuo , Horsley‐Silva, Jennifer L. , Leiman, David A. , Lynch, Kristle L. , Kamal, A. N. , Bredenoord, Albert J. , Dellon, Evan S. , Falk, Gary W. , Peterson, Kathryn A. , Kamal, Afrin N.

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S370-S370

10.14309/01.ajg.0000951668.71231.a7 Get It

Interrater Reliability of Functional Lumen Imaging Probe Panometry and High-Resolution Manometry for the Assessment of Esophageal Motility Disorders
Chen, Joan W. , Khan, Abraham, Chokshi, Reena V. , Clarke, John O. , Garza, Jose M. , Gupta, Milli , Gyawali, C. Prakash , Jain, Anand , Katz, Philip O. , Konda, Vani J. , Lazarescu, Adriana , Lynch, Kristle L. , Schnoll‐Sussman, Felice , Vela, Marcelo F. , Schauer, Jacob M. , Pandolfino, John E. , Carlson, Dustin A. , Clarke, J , Gyawali, C P , Chen, Joan , Khan, Abraham, Fass, Ronnie , Spechler, Stuart Jon , Yadlapati, Rena , Kahrilas, Peter J.

American Journal of Gastroenterology | April 12, 2023 | Volume: 118 | Issue: 8 | Pages: 1334-1343

10.14309/ajg.0000000000002285 Get It

INTRODUCTION: High-resolution manometry (HRM) and functional lumen imaging probe (FLIP) are primary and/or complementary diagnostic tools for the evaluation of esophageal motility. We aimed to assess the interrater agreement and accuracy of HRM and FLIP interpretations. METHODS: Esophageal motility specialists from multiple institutions completed the interpretation of 40 consecutive HRM and 40 FLIP studies. Interrater agreement was assessed using intraclass correlation coefficient (ICC) for continuous variables and Fleiss' κ statistics for nominal variables. Accuracies of rater interpretation were assessed using the consensus of 3 experienced raters as the reference standard. RESULTS: Fifteen raters completed the HRM and FLIP studies. An excellent interrater agreement was seen in supine median integral relaxation pressure (ICC 0.96, 95% confidence interval 0.95–0.98), and a good agreement was seen with the assessment of esophagogastric junction (EGJ) outflow, peristalsis, and assignment of a Chicago Classification version 4.0 diagnosis using HRM (κ = 0.71, 0.75, and 0.70, respectively). An excellent interrater agreement for EGJ distensibility index and maximum diameter (0.91 [0.90–0.94], 0.92 [0.89–0.95]) was seen, and a moderate-to-good agreement was seen in the assignment of EGJ opening classification, contractile response pattern, and motility classification (κ = 0.68, 0.56, and 0.59, respectively) on FLIP. Rater accuracy for Chicago Classification version 4.0 diagnosis on HRM was 82% (95% confidence interval 78%–84%) and for motility diagnosis on FLIP Panometry was 78% (95% confidence interval 72%–81%). DISCUSSION: Our study demonstrates high levels of interrater agreement and accuracy in the interpretation of HRM and FLIP metrics and moderate-to-high levels for motility classification in FLIP, supporting the use of these approaches for primary or complementary evaluation of esophageal motility disorders.
Clinical role of ambulatory reflux monitoring in PPI non‐responders: recommendation statements
Yadlapati, Rena , Gawron, Andrew J. , Gyawali, C. Prakash , Chen, Joan W. , Clarke, John O. , Jain, Anand , Lynch, Kristle L. , Khan, Abraham, Katz, Philip O. , Katzka, David A. , Richter, Joel E. , Schnoll‐Sussman, Felice , Vaezi, Michael F. , Vela, Marcelo F. , Pandolfino, John E. , Chen, Joan , Katzka, D A , Richter, Joel , Vela, Marcelo, Clarke, J , Gyawali, C P , Fass, Ronnie , Khan, Abraham, Spechler, Stuart Jon

Alimentary Pharmacology & Therapeutics | August 16, 2022 | Volume: 56 | Issue: 8 | Pages: 1274-1283

10.1111/apt.17180 Get It

Summary Background Optimal ambulatory reflux monitoring methodology in symptomatic reflux patients continues to be debated. Aims To utilise published literature and expert opinion to develop recommendation statements addressing use of ambulatory reflux monitoring in clinical practice Methods The RAND Appropriateness Method (RAM) was utilised among 17 experts with discussion, revision and two rounds of ranking of recommendation statements. Ambulatory reflux monitoring protocol, methodology and thresholds ranked as appropriate by ≥80% of panellists met the criteria for appropriateness. Results Prolonged (96‐h recommended) wireless pH monitoring off proton pump inhibitor (PPI) was identified as the appropriate diagnostic tool to assess the need for acid suppression in patients with unproven gastro‐oesophageal reflux disease (GERD) and persisting typical reflux symptoms despite once‐daily PPI. Acid exposure time (AET) <4.0% on all days of monitoring with negative reflux‐symptom association excludes GERD and does not support ongoing PPI treatment. Conversely, AET >6.0% across ≥2 days is conclusive evidence for GERD and supports treatment for GERD, while AET >10% across ≥2 days identifies severe acid burden that supports escalation of anti‐reflux treatment. In previously proven GERD, impedance‐pH monitoring on PPI is helpful in defining refractory GERD and mechanisms of continued symptoms; the presence of <40 reflux events, AET <2.0% and a negative reflux‐symptom association does not support escalation of anti‐reflux treatment. In contrast, AET > 4.0% and positive reflux‐symptom association support escalation of anti‐reflux treatment, including use of invasive therapeutics. Conclusions Statements meeting appropriateness for average clinical care have been identified when utilising reflux monitoring in patients with typical reflux symptoms and PPI non‐response.
Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry
Carlson, Dustin A. , Gyawali, C. Prakash , Khan, Abraham, Chen, Joan W. , Chokshi, Reena V. , Clarke, John O. , Garza, Jose M. , Jain, Anand , Katz, Philip O. , Konda, Vani J. , Lynch, Kristle L. , Schnoll‐Sussman, Felice , Vela, Marcelo F. , Prescott, Jacqueline, Baumann, Alexandra J. , Donnan, Erica N. , Pandolfino, John E. , Clarke, J , Gyawali, C P , Khan, Abraham, Yadlapati, Rena , Spechler, Stuart Jon , Kou, Wenjun , Kahrilas, Peter J.

American Journal of Gastroenterology | October 20, 2021 | Volume: 116 | Issue: 12 | Pages: 2357-2366

10.14309/ajg.0000000000001532 Get It

INTRODUCTION: Functional luminal imaging probe (FLIP) panometry can evaluate esophageal motility in response to sustained esophageal distension at the time of sedated endoscopy. This study aimed to describe a classification of esophageal motility using FLIP panometry and evaluate it against high-resolution manometry (HRM) and Chicago Classification v4.0 (CCv4.0). METHODS: Five hundred thirty-nine adult patients who completed FLIP and HRM with a conclusive CCv4.0 diagnosis were included in the primary analysis. Thirty-five asymptomatic volunteers (“controls”) and 148 patients with an inconclusive CCv4.0 diagnosis or systemic sclerosis were also described. Esophagogastric junction (EGJ) opening and the contractile response (CR) to distension (i.e., secondary peristalsis) were evaluated with a 16-cm FLIP during sedated endoscopy and analyzed using a customized software program. HRM was classified according to CCv4.0. RESULTS: In the primary analysis, 156 patients (29%) had normal motility on FLIP panometry, defined by normal EGJ opening and a normal or borderline CR; 95% of these patients had normal motility or ineffective esophageal motility on HRM. Two hundred two patients (37%) had obstruction with weak CR, defined as reduced EGJ opening and absent CR or impaired/disordered CR, on FLIP panometry; 92% of these patients had a disorder of EGJ outflow per CCv4.0. DISCUSSION: Classifying esophageal motility in response to sustained distension with FLIP panometry parallels the swallow-associated motility evaluation provided with HRM and CCv4.0. Thus, FLIP panometry serves as a well-tolerated method that can complement, or in some cases be an alternative to HRM, for evaluating esophageal motility disorders.
Eosinophilic esophagitis: updates on key unanswered questions
Fernandez‐Becker, Nielsen , Raja, Shreya, Scarpignato, Carmelo , Lynch, Kristle L. , Ahuja, Nitin K. , Horsley‐Silva, Jennifer L.

Annals of the New York Academy of Sciences | August 7, 2020 | Volume: 1481 | Issue: 1 | Pages: 30-42

10.1111/nyas.14421 Get It

AbstractEosinophilic esophagitis (EoE) is a clinicopathologic disease characterized by symptoms of esophageal dysfunction and esophageal eosinophilia. In the last decade, there has been a dramatic increase in its prevalence for reasons that are not completely understood. The underlying pathophysiology involves an antigen‐mediated TH2 immune response that draws eosinophils to the esophagus, causing mucosal inflammation, esophageal remodeling, and fibrosis. This ultimately leads to esophageal dysfunction that most commonly manifests as dysphagia. In this review, we will discuss updates on key questions regarding the diagnosis and treatment of EoE.